NCT04610125 2020-10-30Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in ChildrenHebei Senlang Biotechnology Inc., Ltd.Phase NA Unknown30 enrolled